Pfizer RSV vaccine lags GSK’s as head-to-head competition underway
Go back to Pfizer RSV vaccine lags GSK’s as head-to-head competition underway| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 48.13 +0.01 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.12 | 52 Week High | $45.58 | |||
| Open | $48.70 | 52 Week Low | $37.82 | |||
| Day High | $48.80 | P/E | N/A | |||
| Day Low | $47.85 | EPS | $0.00 | |||
| Volume | 2,281,895 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.72 +0.07 (0.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.65 | 52 Week High | $37.39 | |||
| Open | $27.80 | 52 Week Low | $28.25 | |||
| Day High | $27.85 | P/E | 16.80 | |||
| Day Low | $27.42 | EPS | $1.65 | |||
| Volume | 25,551,822 | |||||
